Timur Dogan
Director Técnico/Científico/I+D en CARDIO DIAGNOSTICS HOLDINGS, INC. .
Fortuna: 92 665 $ al 30/04/2024
Perfil
Timur Dogan is currently the Chief Technology Officer at Cardio Diagnostics Holdings, Inc. He previously held the same position at Cardio Diagnostics, Inc. Dr. Dogan obtained his undergraduate, graduate, and doctorate degrees from the University of Iowa.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/04/2024 | 128 345 ( 0.59% ) | 92 665 $ | 30/04/2024 |
Cargos activos de Timur Dogan
| Empresas | Cargo | Inicio |
|---|---|---|
| CARDIO DIAGNOSTICS HOLDINGS, INC. | Director Técnico/Científico/I+D | 25/10/2022 |
Antiguos cargos conocidos de Timur Dogan.
| Empresas | Cargo | Fin |
|---|---|---|
Cardio Diagnostics, Inc.
 Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Director Técnico/Científico/I+D | - |
Formación de Timur Dogan.
| University of Iowa | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
| Cardio Diagnostics Holdings, Inc. | |
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Health Services |
- Bolsa de valores
- Insiders
- Timur Dogan
